Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
Clinical trial NCT03711864 · UNKNOWN
Trial details
- NCT number
- NCT03711864
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2021-10-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.